These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36382475)

  • 41. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
    Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
    Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross Talk between Mesenchymal Stem/Stromal Cells and Innate Immunocytes Concerning Lupus Disease.
    Mahmoudi M; Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S
    Stem Cell Rev Rep; 2022 Dec; 18(8):2781-2796. PubMed ID: 35876958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical application of mesenchymal stem cells in rheumatic diseases.
    Wang Y; Ma D; Wu Z; Yang B; Li R; Zhao X; Yang H; Zhang L
    Stem Cell Res Ther; 2021 Nov; 12(1):567. PubMed ID: 34753496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Clinical Trials of Mesenchymal Stem Cell Therapy in Skin Diseases: An Update and Concise Review.
    Golchin A; Farahany TZ; Khojasteh A; Soleimanifar F; Ardeshirylajimi A
    Curr Stem Cell Res Ther; 2019; 14(1):22-33. PubMed ID: 30210006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow.
    Li M; Zhao Y; Hao H; Han W; Fu X
    Wound Repair Regen; 2015; 23(4):465-82. PubMed ID: 25877885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases.
    Huang F; Thokerunga E; He F; Zhu X; Wang Z; Tu J
    Stem Cell Res Ther; 2022 Jan; 13(1):1. PubMed ID: 34998430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Research Progress on Immunomodulatory Activity and Clinical Application of Mesenchymal Stem Cells-Derived Extracellular Vesicles--Review].
    Zhao J; Jiang Y; Hao SG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):955-958. PubMed ID: 35680833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.
    Hu C; Wu Z; Li L
    J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review.
    Paganelli A; Tarentini E; Benassi L; Kaleci S; Magnoni C
    Clin Exp Dermatol; 2020 Oct; 45(7):824-830. PubMed ID: 32386432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.
    Akimoto K; Kimura K; Nagano M; Takano S; To'a Salazar G; Yamashita T; Ohneda O
    Stem Cells Dev; 2013 May; 22(9):1370-86. PubMed ID: 23231075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects.
    Li M; Jiang Y; Hou Q; Zhao Y; Zhong L; Fu X
    Stem Cell Res Ther; 2022 Apr; 13(1):146. PubMed ID: 35379361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Keratinocyte Growth Factor in the Differentiation of Sweat Gland-Like Cells From Human Umbilical Cord-Derived Mesenchymal Stem Cells.
    Xu Y; Hong Y; Xu M; Ma K; Fu X; Zhang M; Wang G
    Stem Cells Transl Med; 2016 Jan; 5(1):106-16. PubMed ID: 26574554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges.
    Peltzer J; Aletti M; Frescaline N; Busson E; Lataillade JJ; Martinaud C
    Front Immunol; 2018; 9():2013. PubMed ID: 30271402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
    Xu J
    Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue Regeneration.
    Nie WB; Zhang D; Wang LS
    Drug Des Devel Ther; 2020; 14():1241-1256. PubMed ID: 32273686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions.
    Fu X; Li H
    Cell Tissue Res; 2009 Feb; 335(2):317-21. PubMed ID: 19034523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
    Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
    J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical Studies and Clinical Trials with Mesenchymal Stem Cell for Demyelinating Diseases: A Systematic Review.
    Esmaeilizade Z; Mohammadi B; Omrani MD; Ghaderian SMH; Rajabibazl M; Fazeli Z
    Curr Stem Cell Res Ther; 2021; 16(8):1005-1017. PubMed ID: 33557738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.